Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00254709
Status:
COMPLETED
Last Update Posted:
2012-01-31
First Post:
2005-11-11
Brief Title:
Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
Open Pilot Comparative Study to Evaluate the Efficacy and Safety of Two Immunosuppressor Regimens Anti Il-2 Sirolimus Mycophenolate Mophetyl and Steroids Versus Sirolimus Cyclosporine and Withdrawal of Cyclosporine Since the Third Month and Steroids in Elderly Population
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test two different sirolimus-based immunosuppressive regimens for elderly kidney transplant recipients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None